LifeLink Tissue Bank, a non-profit leader in tissue allografts, announced a strategic relationship with Britecyte to advance recovery, processing, and clinical application of adipose tissue.
“We are proud to align ourselves with LifeLink Tissue Bank in this groundbreaking venture,” said Samson Tom, President, CEO, and Co-Founder of Britecyte. “The partnership leverages the strengths of both organizations to advance the field of regenerative medicine, particularly in the clinical use of adipose tissue.”
The collaboration supports a platform that provides an alternative to autologous fat grafting for soft tissue repair, including challenges associated with fat pad atrophy. The partnership was highlighted with the introduction of Liposana™ at the American College of Foot and Ankle Surgeons (ACFAS) meeting in Tampa in February 2024.